Blackrock Health Sciences Trust (NYSE:BME) Shares Bought by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. lifted its position in shares of Blackrock Health Sciences Trust (NYSE:BME) by 26.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,276 shares of the company’s stock after acquiring an additional 2,584 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Blackrock Health Sciences Trust were worth $447,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Raymond James & Associates increased its position in shares of Blackrock Health Sciences Trust by 1.2% during the fourth quarter. Raymond James & Associates now owns 23,126 shares of the company’s stock worth $843,000 after purchasing an additional 271 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Blackrock Health Sciences Trust by 244.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,721 shares of the company’s stock worth $63,000 after purchasing an additional 1,221 shares in the last quarter. LPL Financial LLC increased its position in shares of Blackrock Health Sciences Trust by 121.1% during the fourth quarter. LPL Financial LLC now owns 15,347 shares of the company’s stock worth $559,000 after purchasing an additional 8,405 shares in the last quarter. Rikoon Group LLC increased its position in shares of Blackrock Health Sciences Trust by 26.1% during the fourth quarter. Rikoon Group LLC now owns 20,522 shares of the company’s stock worth $748,000 after purchasing an additional 4,251 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of Blackrock Health Sciences Trust by 1.5% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 19,784 shares of the company’s stock worth $721,000 after purchasing an additional 291 shares in the last quarter.

Shares of BME traded up $0.03 during midday trading on Friday, reaching $37.78. 37,485 shares of the stock were exchanged, compared to its average volume of 31,915. Blackrock Health Sciences Trust has a twelve month low of $32.00 and a twelve month high of $44.00.

The business also recently declared a monthly dividend, which will be paid on Tuesday, April 30th. Investors of record on Monday, April 15th will be given a $0.20 dividend. This represents a $2.40 annualized dividend and a yield of 6.35%. The ex-dividend date of this dividend is Friday, April 12th.

TRADEMARK VIOLATION WARNING: “Blackrock Health Sciences Trust (NYSE:BME) Shares Bought by Raymond James Financial Services Advisors Inc.” was first published by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/raymond-james-financial-services-advisors-inc-raises-position-in-blackrock-health-sciences-trust-bme.html.

Blackrock Health Sciences Trust Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Read More: Retained Earnings

Institutional Ownership by Quarter for Blackrock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.